D3 LLC
Overview
D3 LLC is a venture capital firm based in Tokyo, Japan that invests in early-stage biotech and digital healthcare start-ups.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Grace imaging, Inc. | Jul 2023 | Series A | Co-investor |
| RevolKa Ltd. | May 2025 | Series A Extension | Lead |
| Cyto-Facto Inc. | Apr 2024 | Series A | Lead |
| Shinobi Therapeutics, Inc. | Dec 2023 | Series A | Co-investor |
| Alpha Fusion Inc. | Oct 2024 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is D3 LLC based?
D3 LLC is headquartered in Tokyo, Japan.
When was D3 LLC founded?
D3 LLC was founded in 2017.
How many portfolio companies does D3 LLC have?
D3 LLC has 8 portfolio companies in Caplight's dataset.
What are some companies in D3 LLC's portfolio?
Portfolio companies visible on Caplight include Grace imaging, Inc., RevolKa Ltd., Cyto-Facto Inc., Shinobi Therapeutics, Inc., Alpha Fusion Inc..
What was D3 LLC's most recent investment shown here?
D3 LLC's most recent investment in this portfolio sample was in RevolKa Ltd. in 2025.
What sectors does D3 LLC focus on?
D3 LLC focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does D3 LLC focus on?
D3 LLC typically invests at the Early stage.